COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis

Completed · Phase 3 · Has a placebo group

Conditions studied: Covid19

In brief

A multicenter, adaptive, randomized platform trial evaluating the efficacy and safety of antithrombotic strategies in patients with COVID-19 following hospital discharge

Key facts

Study ID
NCT04650087
Run by
Thomas L. Ortel
People needed
1291
Starts
2021-02-15
Expected to finish
2022-09-23
Last updated by the study team
2025-02-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.